Works matching DE "RESPIRATORY syncytial virus infections"
Results: 2187
Les infections à virus respiratoire syncytial au Nord du Liban — Prévalence au cours de l'hiver 2008.
- Published in:
- Eastern Mediterranean Health Journal, 2010, v. 16, n. 5, p. 539, doi. 10.26719/2010.16.5.539
- By:
- Publication type:
- Article
RSVPreF3 OA respiratory syncytial virus vaccine in older adults: a profile of its use: RSVPreF3 OA respiratory syncytial virus vaccine in older adults: M. Shirley.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 1, p. 3, doi. 10.1007/s40267-024-01125-1
- By:
- Publication type:
- Article
Nirsevimab in the prevention of respiratory syncytial virus lower respiratory tract disease: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 413, doi. 10.1007/s40267-023-01039-4
- By:
- Publication type:
- Article
Improvement in Palivizumab Administration Prior to Discharge for Hospitalized Infants with Hemodynamically Significant Congenital Heart Disease: A Quality Improvement Initiative.
- Published in:
- Pediatric Cardiology, 2024, v. 45, n. 7, p. 1415, doi. 10.1007/s00246-023-03163-4
- By:
- Publication type:
- Article
Respiratory Tract Infection and Risk of Hospitalization in Children with Congenital Heart Defects During Season and Off-Season: A Swedish National Study.
- Published in:
- Pediatric Cardiology, 2016, v. 37, n. 6, p. 1098, doi. 10.1007/s00246-016-1397-4
- By:
- Publication type:
- Article
Influence of meteorological conditions on RSV infection in Portugal.
- Published in:
- International Journal of Biometeorology, 2016, v. 60, n. 12, p. 1807, doi. 10.1007/s00484-016-1168-1
- By:
- Publication type:
- Article
Investigational RSV Vaccine Yields Positive Preliminary Data in Head-to-Head Comparison with Arexvy.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
RSV Mortality Higher than for Influenza B 90 Days After Hospital Discharge: New Data.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
RSV Vaccine Effective Against Hospitalization in Older Adults: Daily Dose.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
RSV Disease Severity Comparable to Unvaccinated COVID-19, Flu: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 4
- By:
- Publication type:
- Article
CDC: Persons with COVID-19, Flu, RSV, Other Respiratory Viruses No Longer Have to Isolate for 5 Days.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Abrysvo or Beyfortus: 2 Questions and Several Facts You Should Know.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Two RSV Vaccines, One Savvy Patient who Asks, "Which One do You Recommend?".
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Chemical Constituents of the Whole Plants of Houttuynia cordata.
- Published in:
- Chemistry of Natural Compounds, 2017, v. 53, n. 2, p. 365, doi. 10.1007/s10600-017-1991-6
- By:
- Publication type:
- Article
Infection prevention and control in Dutch general practices before and during the COVID-19 pandemic and its implications for pandemic preparedness and seasonal respiratory epidemics: a qualitative study on lessons learned.
- Published in:
- BMC Primary Care, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12875-024-02451-z
- By:
- Publication type:
- Article
Respiratory Syncytial Virus Activity -- United States, 2005--2006.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2006, v. 55, n. 47, p. 1277
- By:
- Publication type:
- Article
Treatment-related mortality in the course of acute lymphoblastic leukemia - case report.
- Published in:
- Journal of Pre-Clinical & Clinical Research, 2023, v. 17, n. 4, p. 235, doi. 10.26444/jpccr/175214
- By:
- Publication type:
- Article
Enfermedad por virus sincitial respiratorio en pediatría: más allá del compromiso respiratorio.
- Published in:
- Repertorio de Medicina y Cirugía, 2023, v. 32, n. 2, p. 119, doi. 10.31260/RepertMedCir.01217372.1408
- By:
- Publication type:
- Article
新疆部分地区集约化牛场牛呼吸道合胞体病毒的 流行病学调查.
- Published in:
- Chinese Journal of Preventive Veterinary Medicine / Zhongguo Yufang Shouyi Xuebao, 2022, v. 44, n. 9, p. 934, doi. 10.3969/j.issn.1008-0589.202201008
- By:
- Publication type:
- Article
Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies.
- Published in:
- Science Immunology, 2018, v. 3, n. 21, p. 1, doi. 10.1126/sciimmunol.aar3534
- By:
- Publication type:
- Article
RSV infection in an infant.
- Published in:
- Medicine Today, 2024, v. 25, n. 12, p. 36
- By:
- Publication type:
- Article
The stepwise management approach to paediatric asthma.
- Published in:
- Medicine Today, 2024, v. 25, n. 11, p. 29
- By:
- Publication type:
- Article
Revolutionising RSV infection prevention and control: Unveiling new options in the fight against RSV.
- Published in:
- Medicine Today, 2024, v. 25, n. 7, p. 45
- By:
- Publication type:
- Article
The battle against RSV in Australia begins: New preventives are here.
- Published in:
- Medicine Today, 2024, v. 25, n. 5, p. 49
- By:
- Publication type:
- Article
Bracing for impact: Navigating the complexities of the 2024 influenza season in Australia.
- Published in:
- Medicine Today, 2024, v. 25, n. 5, p. 39
- By:
- Publication type:
- Article
Seasonal vaccination: Bracing for winter.
- Published in:
- Medicine Today, 2024, v. 25, n. 5, p. 12
- By:
- Publication type:
- Article
The dawning of a new era in RSV prevention.
- Published in:
- Medicine Today, 2023, v. 24, n. 7, p. 38
- By:
- Publication type:
- Article
Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Latin America: An Expert Perspective on Knowledge Gaps.
- Published in:
- Pulmonary Therapy, 2024, v. 10, n. 1, p. 1, doi. 10.1007/s41030-024-00253-3
- By:
- Publication type:
- Article
Occult Serious Bacterial Infections in Neonates and Infants Up to Three Months of Age with Bronchiolitis: Are Invasive Cultures Required?
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 8, p. 702, doi. 10.3390/antibiotics13080702
- By:
- Publication type:
- Article
Associations between Bovine Coronavirus and Bovine Respiratory Syncytial Virus Infections and Productivity, Health Status and Occurrence of Antimicrobial Resistance in Swedish Dairy Herds.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 6, p. 641, doi. 10.3390/antibiotics10060641
- By:
- Publication type:
- Article
Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND).
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 175, doi. 10.3390/vaccines13020175
- By:
- Publication type:
- Article
Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND).
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 175, doi. 10.3390/vaccines13020175
- By:
- Publication type:
- Article
An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 52, doi. 10.3390/vaccines13010052
- By:
- Publication type:
- Article
Favorable Nonclinical Safety Profile of RSVpreF Bivalent Vaccine in Rats and Rabbits.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 26, doi. 10.3390/vaccines13010026
- By:
- Publication type:
- Article
RSV Vaccine with Nanoparticle-Based Poly-Sorbitol Transporter (PST) Adjuvant Improves Respiratory Protection Against RSV Through Inducing Both Systemic and Mucosal Humoral Immunity.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1354, doi. 10.3390/vaccines12121354
- By:
- Publication type:
- Article
A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal Immunization.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1351, doi. 10.3390/vaccines12121351
- By:
- Publication type:
- Article
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1232, doi. 10.3390/vaccines12111232
- By:
- Publication type:
- Article
Evaluating the Effectiveness of Nirsevimab in Reducing Pediatric RSV Hospitalizations in Spain.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1160, doi. 10.3390/vaccines12101160
- By:
- Publication type:
- Article
Maternal Vaccination for the Prevention of Infantile RSV Disease: An Overview of the Authorized, In-Progress, and Rejected Vaccine Candidates.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 980, doi. 10.3390/vaccines12090980
- By:
- Publication type:
- Article
Vaccines for Respiratory Viruses—COVID and Beyond.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 936, doi. 10.3390/vaccines12080936
- By:
- Publication type:
- Article
The Central Conserved Peptides of Respiratory Syncytial Virus G Protein Enhance the Immune Response to the RSV F Protein in an Adenovirus Vector Vaccine Candidate.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 807, doi. 10.3390/vaccines12070807
- By:
- Publication type:
- Article
Age-Stratified Seroprevalence of Respiratory Syncytial Virus: Analysis Using Prefusion F and G Protein Antibodies.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 513, doi. 10.3390/vaccines12050513
- By:
- Publication type:
- Article
Respiratory Syncytial Vaccination: Parents' Willingness to Vaccinate Their Children.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 418, doi. 10.3390/vaccines12040418
- By:
- Publication type:
- Article
Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 383, doi. 10.3390/vaccines12040383
- By:
- Publication type:
- Article
Vaccination for Respiratory Syncytial Virus: A Narrative Review and Primer for Clinicians.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1809, doi. 10.3390/vaccines11121809
- By:
- Publication type:
- Article
Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1807, doi. 10.3390/vaccines11121807
- By:
- Publication type:
- Article
New Insights on Respiratory Syncytial Virus Prevention.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1797, doi. 10.3390/vaccines11121797
- By:
- Publication type:
- Article
Respiratory Syncytial Virus: Willingness towards a Future Vaccine among Pregnant Women in Italy.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1691, doi. 10.3390/vaccines11111691
- By:
- Publication type:
- Article